NEWS & EVENTS

ULLINK and Enfusion Partner to Offer Allocation and Post-Trade Matching Service via NYFIX

pdf_icon_small View printable version


ULLINK and Enfusion Partner to Offer Allocation and Post-Trade Matching Service via NYFIX
Partnership extends existing relationship with FIX-based post-trade support for Enfusion’s buy-side customers

NEW YORK, 18 July, 2017– ULLINK, a global provider of electronic trading and connectivity solutions to the financial community, and Enfusion, leading provider of innovative, cloud-based investment management software solutions, today announced a new solution for users of Enfusion’s Integráta buy-side Order & Execution Management System (OEMS).

The new solution utilizes ULLINK’S NYFIX network to automate allocation and post-trade confirmation/affirmation workflows, generating significant efficiency and cost benefits for Enfusion clients. Through an extension of Enfusion’s Integráta platform, users can now leverage NYFIX to send allocation instructions and automatically match broker confirmations in near real-time – seamlessly catching errors and inhibiting costly trade breaks. The new solution also gives Integráta users fully-integrated Straight-Through-Processing (STP) across asset classes, applicable to both domestic and international trade flows.

Enfusion President, Jason Morris notes “With the move to T+2 settlement later this year for US equities and general shrinking of settlement windows world-wide, our clients demand additional support for automating their allocation and affirmation workflows. Based on our strong partnership with ULLINK and the scale, flexibility and reliability of the NYFIX network, our close integration of Integráta and NYFIX for post-trade allows us to provide the most efficient and cost-effective solution for clients.”

ULLINK’s Global Business Development Manager, Philippe Carré, added, “We are delighted to extend our partnership with Enfusion from order routing to post-trade. Based on analysis of our own message traffic, the usage of FIX for allocation and post-trade workflows is becoming widespread. The flexibility of our NYFIX network to support all FIX message types across all common FIX versions and asset classes is key to our growth in this area, and we expect that growth to accelerate as more firms move to FIX to automate their post-trade processes.”

Enfusion’s market leading solution, Integráta, is the premiere investment management platform, seamlessly integrating multi-asset class solutions for front, middle and back office through a single data set. ULLINK’s award-winning NYFIX network is recognized as one of the most secure, performant, reliable networks in the industry. With a global trading community of more than 1,500 member firms, NYFIX provides buy-side institutions with access to domestic and international brokers across all asset classes using industry-standard FIX protocol.

Contacts:

ULLINK
Mireille Adebiyi                                             Marketing & Communication Director
Tel.: +33 (0)1 33 49 95 30 00                     mireille.adebiyi@ullink.com

Follow ULLINK on Twitter @Ullink_News and LinkedIn

ENFUSION
Alicia Verason                                                Marketing Manager
Tel.: +1 (312)265-6856                                 averason@enfusionsystems.com

Follow ENFUSION on Twitter @EnfusionSystems and LinkedIn

About ENFUSION

For more than 10 years, Enfusion has provided technology innovation and support to the global investment management industry. Our market leading solution, Integráta, automates and simplifies investment management on a single platform and seamlessly provides asset managers full front-to-back office functionality across all asset classes.
As a strategic partner to nearly 300 top-tier firms worldwide, our clients manage more than $300+ billion in the hedge fund, institutional investment and wealth management industries. Enfusion is headquartered in Chicago, with offices in New York, London, Dublin and Hong Kong.
For more information, please contact sales@enfusionsystems.com or visit http://www.enfusionsystems.net.